Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Basit Öğe Kaydı
dc.authorid0000-0001-8650-299X
dc.authorid0000-0002-7584-3868
dc.authorid0000-0003-4642-3693
dc.authorwosidYumuk, Perran Fulden/A-6189-2018
dc.authorwosidKucukoner, Mehmet/E-1162-2013
dc.authorwosidUrvay, Semiha/AAM-2335-2021
dc.authorwosidKilickap, Saadettin/AAP-3732-2021
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidPaydas, Semra/F-3132-2018
dc.authorwosid, yesim/AAD-7194-2020
dc.contributor.authorKilickap, S.
dc.contributor.authorÖztürk, A.
dc.contributor.authorKaradurmuş, N.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorYumuk, P.
dc.contributor.authorCicin, İrfan
dc.contributor.authorTunali, D.
dc.contributor.authorYetişyiğit, Tarkan
dc.date.accessioned2022-05-11T14:40:56Z
dc.date.available2022-05-11T14:40:56Z
dc.date.issued2018
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı
dc.description.abstract[No Abstract Available]
dc.identifier.endpageS478
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue10en_US
dc.identifier.startpageS477
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8979
dc.identifier.volume13
dc.identifier.wosWOS:000454014501235
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorYetişyiğit, Tarkan
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of Thoracic Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNSCLC
dc.subjectALK inhibitor
dc.subjectcrizotinib
dc.titleCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu